Inventor · disambiguated record
Hongxing Zhou
Also filed as: ZHOU HONGXING
9 granted patents·15 pending applications·272 citations·filing 1996–2023
90Inventor score
Files withPROVIVA THERAPEUTICS HONG KONG LTD8IMMUNEX CORP2KANNAN GUNASEKARAN2ZHOU HONGXING2ZTE CORP2
Top patents by PatentIndex Score
24 records- 0195US9200060B2Monomeric antibody FcKANNAN GUNASEKARAN·Filed 2010·Granted Dec 1, 2015·46 cites·10 claims
- 0295US7638606B2Antibodies that bind interleukin-4 receptorIMMUNEX CORP·Filed 2004·Granted Dec 29, 2009·60 cites·9 claims
- 0394US8846042B2Multi-specific FAB fusion proteins and methods of useZHOU HONGXING·Filed 2012·Granted Sep 30, 2014·83 cites·4 claims
- 0494US7872113B2Nucleic acids encoding antibodies that bind interleukin-4 receptorIMMUNEX CORP·Filed 2009·Granted Jan 18, 2011·25 cites·12 claims
- 0588US9308258B2Stable and aggregation free antibody FC molecules through CH3 domain interface engineeringKANNAN GUNASEKARAN·Filed 2010·Granted Apr 12, 2016·13 cites·17 claims
- 0684US11013800B2Multi-specific Fab fusion proteins comprising a CD3-binding Fab fragment with N-terminal fusion to binding domains and methods of useEVIVE BIOTECH LTD·Filed 2014·Granted May 25, 2021·7 cites·27 claims
- 0771US5759947ABifunctional catalyst containing multimetal oxidesFiled 1996·Granted Jun 2, 1998·38 cites·15 claims
- 0862US2024182537A1Il-15 procytokine antibody fusion proteinsPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2023·Application pending·0 cites
- 0962US2021393776A1Bispecific fab fusion proteins comprising a cd3-binding fab fragment with n-terminal fusion to a binding domain and methods of useITABMED HK LTD·Filed 2021·Application pending·0 cites
- 1061US2024218037A1Il-2 procytokine antibody fusion proteinsPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2023·Application pending·0 cites
- 1151US2023399371A1Il-12 compositions and methods of use thereofPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2021·Application pending·0 cites
- 1250US2022195041A1Precursor tri-specific antibody constructs and methods of use thereofIMMUNORIZON LTD·Filed 2020·Application pending·0 cites
- 1350US2023257453A1Collagen-targeted fusion proteins and antibodiesPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2021·Application pending·0 cites
- 1450US2023250193A1Antibodies to fibroblast activation protein and b7h3PROVIVA THERAPEUTICS HONG KONG LTD·Filed 2021·Application pending·0 cites
- 1550US2011081361A1Antibodies that bind interleukin-4 receptorCARTER PAUL J·Filed 2010·Application pending·0 cites
- 1649US2023226202A1Il-2/il15 compositions and methods of use thereofPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2021·Application pending·0 cites
- 1747US2022378933A1Il-2 compositions and methods of use thereofPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2020·Application pending·0 cites
- 1846US11700034B2Method and device for extracting broadband error calibration parameters and computer-readable storage mediumZTE CORP·Filed 2019·Granted Jul 11, 2023·0 cites·16 claims
- 1946US2023226203A1Activatable procytokinesPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2020·Application pending·0 cites
- 2046US2008124340A1Erythropoietin receptor agonistsBORGES LUIS G·Filed 2007·Application pending·0 cites
- 2142US2020051987A1Anti-fuse, method for fabricating anti-fuse, and storage apparatus thereofSHENZHEN WEITONGBO TECH CO LTD·Filed 2019·Application pending·0 cites
- 2238US12040810B2Time-interleaved successive approximation analog to digital converter and calibration method thereofZTE CORP·Filed 2020·Granted Jul 16, 2024·0 cites·12 claims
- 2338US2013115215A1Domain insertion immunoglobulinZHOU HONGXING·Filed 2011·Application pending·0 cites
- 2432US2012039880A1FRAGMENTATION RESISTANT IgG1 Fc-CONJUGATESYAN BOXU·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hongxing Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →